Nader was clear, enunciated his words properly, and spoke slowly so that his audience could understand him. Of course, the message that he was hopeful of FDA and MHRA approval for leronlimab with the CD-12 results next week didn't hurt. He also managed to get HIV and TNBC into the conversation. A great job considering the time that he had.

I have been critical of NP because of his strong accent and inability to make himself clear. He turned it around with this interview. Being interviewed by Neil Cavuto also has to help.